Stem-Cell-Based Strategies for the Treatment of Parkinson’s Disease
- 1 July 2007
- journal article
- review article
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 4 (4) , 339-347
Abstract
Background: Cell transplantation to replace lost neurons in neurodegenerative diseases such as Parkinson’s disease (PD) offers a hopeful prospect for many patients. Previously, fetal grafts have been shown to survive, integrate and induce functional recovery in PD patients. However, limited tissue availability has haltered the widespread use of this therapy and begs the demand for alternative tissue sources. In this regard, stem cells may constitute one such source. Objective/Methods: In this review we outline various types of stem cells currently available and provide an overview of their possible application for PD. We address not only the obvious possibility of using stem cells in cell replacement therapy but also the benefits of stem cell lines in drug discovery. Results/Conclusion: Stem cells carrying reporters or mutations in genes linked to familial PD are likely to contribute to the identification of new drug targets and subsequent development of new drugs for PD. Thus, stem cells are, and will be more so in the future, invaluable tools in the quest for new therapies against neurodegenerative diseases such as PD.Keywords
This publication has 66 references indexed in Scilit:
- Self-renewal of embryonic stem cells by a small moleculeProceedings of the National Academy of Sciences, 2006
- Enhanced Yield of Neuroepithelial Precursors and Midbrain-Like Dopaminergic Neurons from Human Embryonic Stem Cells Using the Bone Morphogenic Protein Antagonist NogginStem Cells, 2006
- Genetic selection of sox1GFP‐expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantationJournal of Neurochemistry, 2006
- Neurogenin2 identifies a transplantable dopamine neuron precursor in the developing ventral mesencephalonExperimental Neurology, 2006
- Identification of Intrinsic Determinants of Midbrain Dopamine NeuronsCell, 2006
- Synthetic small molecules that control stem cell fateProceedings of the National Academy of Sciences, 2003
- Conversion of embryonic stem cells into neuroectodermal precursors in adherent monocultureNature Biotechnology, 2003
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Neural plate patterning: Upstream and downstream of the isthmic organizerNature Reviews Neuroscience, 2001
- Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cellsNature Biotechnology, 2000